Phase I/II study of G3139 (Genasense) [oblimersen] in patients With Waldenstrom's macroglobulinaemia
Phase of Trial: Phase I/II
Latest Information Update: 08 Jan 2016
At a glance
- Drugs Oblimersen (Primary)
- Indications Waldenstrom's macroglobulinaemia
- Focus Adverse reactions
- 28 Aug 2007 Status changed from in progress to completed.
- 12 Jul 2007 New trial record.